MLchartDataset catalogue

Tarceva

Term · Oncology and biomedicine · MLC-T-ONC-008523

A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Tarceva blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, and OSI-774.

Table 1. Record
IdentifierMLC-T-ONC-008523
FieldOncology and biomedicine
SynonymsCP-358,774; erlotinib hydrochloride; OSI-774
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008523",
  "term": "Tarceva",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Tarceva blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, and OSI-774.",
  "synonyms": [
    "CP-358,774",
    "erlotinib hydrochloride",
    "OSI-774"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tarceva/"
}

Record 15,997 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.